BIOMAT Database Logo BIOMAT Database Logo

[Experience in vitaprost treatment of patients with chronic abacterial prostatitis and prostatic adenoma after prostatic arteries embolism]. 2011

Ia V Iakovets, and E A Iakovets, and A I Neĭmark, and A A Karpenko, and D D Arzamastsev

Pain and abnormal spermatogenesis are among symptoms deteriorating quality of life in patients with chronic prostatitis. Rectal suppositories vitaprost have no side effects, relieve pain, correct spermatogenesis. The effect of vitaprost treatment persists for 3 months and longer. Prostatic arteries embolization with vitaprost suppositories as preoperative preparation is a good alternative to surgical treatment in patients with prostatic adenoma.

UI MeSH Term Description Entries
D008297 Male Males
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011470 Prostatic Hyperplasia Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both. Adenoma, Prostatic,Benign Prostatic Hyperplasia,Prostatic Adenoma,Prostatic Hyperplasia, Benign,Prostatic Hypertrophy,Prostatic Hypertrophy, Benign,Adenomas, Prostatic,Benign Prostatic Hyperplasias,Benign Prostatic Hypertrophy,Hyperplasia, Benign Prostatic,Hyperplasia, Prostatic,Hyperplasias, Benign Prostatic,Hypertrophies, Prostatic,Hypertrophy, Benign Prostatic,Hypertrophy, Prostatic,Prostatic Adenomas,Prostatic Hyperplasias, Benign,Prostatic Hypertrophies
D011472 Prostatitis Infiltration of inflammatory cells into the parenchyma of PROSTATE. The subtypes are classified by their varied laboratory analysis, clinical presentation and response to treatment. Acute Bacterial Prostatitis,Asymptomatic Inflammatory Prostatitis,Chronic Bacterial Prostatitis,Chronic Prostatitis with Chronic Pelvic Pain Syndrome,Acute Bacterial Prostatitides,Asymptomatic Inflammatory Prostatitides,Bacterial Prostatitides, Acute,Bacterial Prostatitides, Chronic,Bacterial Prostatitis, Acute,Bacterial Prostatitis, Chronic,Chronic Bacterial Prostatitides,Inflammatory Prostatitis, Asymptomatic,Prostatitides,Prostatitides, Chronic Bacterial
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004617 Embolism Blocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream. Embolus,Embolisms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000285 Administration, Rectal The insertion of drugs into the rectum, usually for confused or incompetent patients, like children, infants, and the very old or comatose. Anal Drug Administration,Drug Administration, Rectal,Instillation, Rectal,Rectal Drug Administration,Drug Administration, Anal,Rectal Administration,Administration, Anal Drug,Administration, Rectal Drug,Administrations, Anal Drug,Administrations, Rectal,Administrations, Rectal Drug,Anal Drug Administrations,Drug Administrations, Anal,Drug Administrations, Rectal,Instillations, Rectal,Rectal Administrations,Rectal Drug Administrations,Rectal Instillation,Rectal Instillations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013488 Suppositories Medicated dosage forms that are designed to be inserted into the rectal, vaginal, or urethral orifice of the body for absorption. Generally, the active ingredients are packaged in dosage forms containing fatty bases such as cocoa butter, hydrogenated oil, or glycerogelatin that are solid at room temperature but melt or dissolve at body temperature. Rectal Suppositories,Vaginal Suppositories,Vaginal Suppository,Suppositories, Rectal,Suppositories, Vaginal,Suppository, Vaginal

Related Publications

Ia V Iakovets, and E A Iakovets, and A I Neĭmark, and A A Karpenko, and D D Arzamastsev
[Vitaprost efficacy in patients with chronic abacterial prostatitis].
January 2006, Urologiia (Moscow, Russia : 1999),
Ia V Iakovets, and E A Iakovets, and A I Neĭmark, and A A Karpenko, and D D Arzamastsev
[Use of oral vitaprost in the treatment of chronic abacterial prostatitis].
January 2006, Urologiia (Moscow, Russia : 1999),
Ia V Iakovets, and E A Iakovets, and A I Neĭmark, and A A Karpenko, and D D Arzamastsev
[Vitaprost-forte in the treatment of patients with prostatic adenoma].
January 2011, Urologiia (Moscow, Russia : 1999),
Ia V Iakovets, and E A Iakovets, and A I Neĭmark, and A A Karpenko, and D D Arzamastsev
[Administration of oral vitaprost for prevention of exacerbations of chronic abacterial prostatitis].
January 2009, Urologiia (Moscow, Russia : 1999),
Ia V Iakovets, and E A Iakovets, and A I Neĭmark, and A A Karpenko, and D D Arzamastsev
[Vitaprost forte efficacy in patients with prostatic adenoma].
January 2008, Urologiia (Moscow, Russia : 1999),
Ia V Iakovets, and E A Iakovets, and A I Neĭmark, and A A Karpenko, and D D Arzamastsev
[Efficiency of vitaprost in patients with chronic prostatitis].
January 2012, Urologiia (Moscow, Russia : 1999),
Ia V Iakovets, and E A Iakovets, and A I Neĭmark, and A A Karpenko, and D D Arzamastsev
[Efficacy of vitaprost forte in patients with prostatic adenoma].
January 2008, Urologiia (Moscow, Russia : 1999),
Ia V Iakovets, and E A Iakovets, and A I Neĭmark, and A A Karpenko, and D D Arzamastsev
[Vitaprost forte in the therapy of patients with prostatic adenoma].
January 2007, Urologiia (Moscow, Russia : 1999),
Ia V Iakovets, and E A Iakovets, and A I Neĭmark, and A A Karpenko, and D D Arzamastsev
[Treatment of prostatic adenoma with concomitant chronic bacterial prostatitis].
January 2011, Urologiia (Moscow, Russia : 1999),
Ia V Iakovets, and E A Iakovets, and A I Neĭmark, and A A Karpenko, and D D Arzamastsev
[Prostagut forte treatment of patients with prostatic adenoma with comorbid chronic prostatitis].
January 2012, Urologiia (Moscow, Russia : 1999),
Copied contents to your clipboard!